Table 1 of Micheal, Mol Vis 2014; 20:1471-1479.


Table 1. Genotype frequencies in patients and controls.

Genotypes Patientsn=513 (%) Controlsn=233 (%) p (χ2) p (χ2) OR (95% CI)
CDKN2B-AS1 rs4977756
AA 281 (54.7) 135 (57.9) 0.63 (0.91) Reference
AG 197 (38.5) 81 (34.8) 0.35 (0.85) 0.86 (0.61–1.21)
GG 35 (6.8) 17 (7.3) 0.97 (0.00) 0.99 (0.51–1.92)
CDKN2B rs1063192
TT 270 (52.6) 127 (54.5) 0.87 (0.26) Reference
CT 206 (40.2) 89 (38.2) 0.60 (0.26) 0.92 (0.65–1.29)
CC 37 (7.2) 17 (7.3) 0.94 (0.01) 0.98 (0.51–1.87)
ATOH7 rs1900004
CC 230 (44.9) 110 (47.2) 0.75 (0.57) Reference
CT 231 (45.0) 98 (42.1) 0.47 (0.51) 0.89 (0.63–1.25)
TT 52 (10.1) 25 (10.7) 0.98 (0.00) 0.99 (0.57–1.75)
CAV1 rs4236601
GG 296 (57.7) 150 (64.4) 0.06 (5.45) Reference
AG 183 (35.7) 76 (32.6) 0.23 (1.38) 0.82 (0.58–1.16)
AA 34 (6.6) 7 (3.0) 0.02 (4.71) 2.46 (1.01–6.24)
TMCO1 rs4656461
AA 420 (81.9) 162 (69.5) <0.0001 (14.32) Reference
AG 91 (17.7) 69 (29.6) <0.001 (13.68) 0.51 (0.35–0.74)
GG 2 (0.4) 2 (0.9) 0.32 (0.97) 0.39 (0.04–3.86)
SIX1 rs10483727
CC 104 (20.3) 46 (19.7) 0.64 (0.87) Reference
CT 261 (50.9) 112 (48.1) 0.88 (0.02) 0.97 (0.63–1.50)
TT 148 (28.8) 75 (32.2) 0.54 (0.36) 0.87 (0.55–1.39)